Volz et al. conducted a retrospective analysis to find out more about the use of a proprietary lavender oil preparation over a longer period of time (>3 or >6 months) and to evaluate the usage behavior of 12-17-year-olds. For this purpose, they analyzed large data sets from Switzerland and Germany. The results are very informative and confirm the positive results of this widespread treatment option in a real-world setting.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities
Exacerbation frequency is associated with cardiopulmonary disease burden
- Multiple myeloma
DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14
- Catheter ablation for atrial fibrillation 2025
Pulsed field versus radio frequency – where do we stand?
- Atopic dermatitis
From skin barrier disorder to atopic march?
- From the late residual valve to independent therapy
Tricuspid interventions 2025
- Brain health